Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Scorpion Therapeutics
Biotech
Lilly inks $2.5B Scorpion buyout in twist to breast cancer tale
Lilly is reenergizing its attempt to challenge Novartis and Roche with a deal to buy Scorpion’s PI3Kα pipeline for up to $2.5 billion.
Nick Paul Taylor
Jan 13, 2025 9:55am
Where are they now? Catching up with past Fierce 15 honorees
Oct 18, 2024 9:39am
Scorpion snaps up $150M series C to broaden clinical plans
Jul 16, 2024 9:40am
OnKure hitches Reneo's ride to Nasdaq, with $65M PIPE to boot
May 13, 2024 10:36am
Scorpion taps new CEO, CMO—Chutes & Ladders
Jan 5, 2024 9:30am
Axel Hoos and Michael Streit depart Scorpion
Jan 4, 2024 1:28pm
